Komrower lecture: Treatment of inborn errors of metabolism: A review
Author:
- 26 October 2005
- journal article
- review article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 29 (2-3) , 275-278
Abstract
Although the treatment of a small number of inborn errors is very good, for the majority the outcome is less satisfactory. This review examines current treatment critically and suggests how the information on which decisions about the management of patients with inborn errors might be improved.Keywords
This publication has 20 references indexed in Scilit:
- Methylmalonic and propionic acidurias: Management without or with a few supplements of specific amino acid mixtureJournal of Inherited Metabolic Disease, 2006
- Nutrition therapy of organic acidaemias with amino acid‐based formulas: Emphasis on methylmalonic and propionic acidaemiaJournal of Inherited Metabolic Disease, 2005
- Age dependence of endogenous galactose formation in Q188R homozygous galactosemic patientsMolecular Genetics and Metabolism, 2004
- NovelOCTN2mutations: No genotype–phenotype correlations: Early carnitine therapy prevents cardiomyopathyAmerican Journal of Medical Genetics, 2002
- Outcome of the First 3-Years of a DNA-Based Neonatal Screening Program for Glutaric Acidemia Type 1 in Manitoba and Northwestern Ontario, CanadaMolecular Genetics and Metabolism, 2002
- Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's DiseaseNew England Journal of Medicine, 2001
- Serum lysosomal enzyme abnormalities in galactosaemiaThe Lancet, 1992
- Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenaseThe Lancet, 1992
- Long‐term prognosis in galactosaemia: Results of a survey of 350 casesJournal of Inherited Metabolic Disease, 1989
- Long-term Follow-up of GalactosaemiaArchives of Disease in Childhood, 1970